European Commission logo
English English
CORDIS - EU research results

Article Category

Content archived on 2023-03-23

Article available in the following languages:


Transnational access to large prospective cohorts in Europe – BBMRI-LPC Call for proposals

Brussels: A FP7-funded multinational BBMRI-LPC project (Biobanking and Biomolecular Resources Research Infrastructure-Large Prospective Cohorts) brings together large prospective cohorts across Europe to enhance collaborative transnational research. The first BBMRI-LPC call for study proposals is now open.

BBMRI-LPC will help initiate and support research projects conducted across multiple large prospective cohorts (LPC) within Europe. This is a unique opportunity for European scientists to gain access to the unique collections of data and biospecimens from high quality cohorts and carry out high priority research projects. The BBMRI-LPC call offers a unique opportunity for research investigators throughout Europe to carry out high priority research projects at reduced cost by offering free access to large collections of samples and data from European populations. Study proposals are targeted to the broad field of common chronic diseases including cardiovascular disease, Type II diabetes and cancer. For further information: Media Enquiries Jessica Hadjis ISC Intelligence in Science Email: Mob: +32 487 163 107 Or Vera Hörmann ISC Intelligence in Science Email: Tel: +32 2 8888 104 Editor’s Note BBMRI-ERIC Biological resources, such as cells, tissues or biomolecules are considered as the essential raw material for the advancement of biotechnology, human health, and for research and development in life sciences. The pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) improves the accessibility and interoperability of the existing comprehensive collections, either population-based or clinical-oriented, of biological samples from different (sub) populations of Europe. These collections include the attached data on factors such as health status, nutrition, lifestyle, and environmental exposure of the study subjects. Combined with the expertise of the clinicians, pathologists, bio-informaticians, and molecular biologists involved, a globally unmatched, Europe-wide platform for translational medical research is envisaged with the aim to develop personalised medicine and disease prevention for the benefit of European citizens. In particular, BBMRI will ensure sustainable access to key resources required for science-based responses to several of the health-related grand challenges, such as sustainable health care for ageing population, new pandemics, and security threats. To reach this goal, also biotech and pharmaceutical industry must have a possibility to collaborate with academic researchers in order to fully realise the enormous potential of European biobanking. In addition to clinical, ethical and legal experts, patient communities are involved to achieve standards and guidelines that properly balance individual values, such as protection of privacy and informed consent, with shared values of facilitated access to progress in health care and disease prevention. This can only be achieved by a distributed research infrastructure with operational units in most, if not all, European Member States. BBMRI is implemented under the ERIC (European Research Infrastructure Consortium) legal entity. BBMRI-ERIC foresees a Central Executive Management Office ("Headquarter") in Austria that coordinates the interaction of National Nodes established in several Member States. The Central Executive Management Office provides a common access portal to resources available at BBMRI-ERIC Partners as well as appropriate facilities and expertise. For further information:


Austria, Belgium, Bulgaria, Cyprus, Czechia, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, United Kingdom